期刊文献+

注射用硫酸头孢噻利与三种输液配伍的稳定性观察 被引量:1

Observation about compatible stability of cefoselis sulfate mixed injection with different kinds of transfusions
原文传递
导出
摘要 目的观察注射用硫酸头孢噻利与三种输液的配伍稳定性,为临床合理配伍使用提供依据。方法在30℃下,将注射用硫酸头孢噻利分别与5%果糖注射液、果糖氯化钠注射液和转化糖注射液配伍,在6h内观察配伍液的外观、pH值变化,并采用高效液相色谱法测定三种配伍液中注射用硫酸头孢噻利的含量。结果注射用硫酸头孢噻利与三种输液在6h内含量、pH值及外观均无明显变化。结论注射用硫酸头孢噻利与三种输液在30℃,6h内配伍稳定。 Objective To investigate the compatible stability of cefoselis sulfate mixed with different kinds of transfusions(5% fructose injection + cefoselis sulfate,fructose sodium chloride injection + cefoselis sufate and invert sugar injection + cefoselis sulfate). Methods At 30℃, the above different mixed solutions' appearance and pH changes within six hours were observed, and determine the concentration of cefoselis sulfate by HPLC. Results There were noobvious changes concern to the concentration, pH and appearance in the mixed solutions. Conclusion At 30℃, different cefoselis sulfate mixed injection all have good compatible stability within 6 hours.
出处 《中国基层医药》 CAS 2013年第2期217-219,I0003,共4页 Chinese Journal of Primary Medicine and Pharmacy
关键词 头孢噻利 输液 配伍 高效液相色谱法 稳定性 Cefoselis Infusion Campatibility HPLC Stability
  • 相关文献

参考文献5

二级参考文献48

  • 1郭根和,潘葳,苏德森,饶秋华,陈涵贞.高效液相色谱法测定对虾中五种磺胺类药物残留[J].现代科学仪器,2005,22(1):70-72. 被引量:15
  • 2李军,雍炜,李刚,杨强,储晓刚,唐英章.食品中苏丹色素的液相色谱分析方法[J].食品工业科技,2005,26(11):157-160. 被引量:10
  • 3林裕.高效液相色谱法测定食品中黄曲霉毒素[J].中国热带医学,2006,6(4):677-678. 被引量:11
  • 4国家药典委员会.中国药典:二部[S].中国医药科技出版社,2010:附录IXC.
  • 5Jones RN. Preliminary interpretive susceptibility testing cri teria for FK-037 with 30 microgram disks[J]. J Clin Microbi ol, 1994, 32(4):1104-1106.
  • 6松本佳巳,横田好子,若杉昌宏,他.Cefoselis老含扫各种注射用βテクタム系蘖に对する2000年度临床分离菌の感受性[J].PharmaMedica,2002,20(5):168-193.
  • 7Giamarellos-Bourbouli5 EJ, Greeka P, Tsitsika A, et al. lnvitro activity of FK 037 (Cefoselis), a novel 4th generation cephalosporin, compared to cefepime and cefpirome on noso comial staphylococci and gram-negative isolates [J]. Diagn Microbiol Infect Dis, 2000, 36(3) :185-191.
  • 8Kuriyama T, Karasawa T, Nakagawa K, et al. Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactarn antibiotics[J]. Oral Microbioi Immunol, 2002, 17(5):285-289.
  • 9Neu HC, Chin NX, Huang HB. In vitro activity and betalactamase stability of FK-037, a parenteral cephalosporin[J]. Antimierob Agents Chemother, 1993, 37 (3) : 566-573.
  • 10Climo MW, Markowitz SM, Williams DS, et al. Comparison of the in-vitro and iwvi'vo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species[J]. J Antimicrob Chemother, 1997, 40(1) :59-66.

共引文献48

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部